We ran a flow cytometry experiment where Fc blockers were added into the antibody cocktail. Other antibodies added include:

1. anti-CD3-PE-Cy7

2. anti-CD4-APC

3. anti-CD8-AmCyan

4. anti-CD14-APC-Cy7

5. anti-CD19-BV605

6. anti-pSTAT1-AF488

7. anti-pTAT3-PE

8. anti-pSTAT5-BV421

Before Fc blockers were added, the monocyte population expressed high levels of CD3. We speculated that the anti-CD3 antibody might undergo non-specific binding to FcR. However, adding Fc blockers did not change the CD3 expression.

Is there any possible scenario of why this happened?

Similar questions and discussions